Who invested in Embera NeuroTherapeutics?
Embera NeuroTherapeutics's investors include Louisiana Funds, Themelios Ventures and HRA Pharma.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$7.0Mraised across 4 rounds since 2010, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $2.3M sold, first sale Dec 2014
No investor was named in the report.
From a historical funding record
Reported by finsmes.comSEC filing: $3.5M sold, first sale Aug 2011
No investor was named in the report.
From a historical funding recordSEC filing: $490K sold, first sale Oct 2009
From the SEC filings it signed: 1 on the team.
On the board, as filediJohn B. BeairdJoseph B. LovettRoss B. Barrett
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Embera NeuroTherapeutics's investors include Louisiana Funds, Themelios Ventures and HRA Pharma.
Embera NeuroTherapeutics has raised $7.0M across 4 rounds since 2010. One round did not disclose an amount, so the total is a floor.
Embera NeuroTherapeutics's most recent round was a Series A of $2.0M in Apr 2015.
Embera NeuroTherapeutics's largest round on record is $4.5M (Series A), in Aug 2011.
Embera NeuroTherapeutics's first round on record, in Aug 2011, was backed by Louisiana Funds and Themelios Ventures.
Embera NeuroTherapeutics's latest named round is a Series A, in Apr 2015.
Embera NeuroTherapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.